C. White

发表

MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.

M. Warzynski, M. Rosen, R. Otto, 1991, Leukemia research.

Natural killer lymphocyte blast crisis of chronic myelogenous leukemia

M. Golightly, M. Warzynski, R. Otto, 1989, American journal of hematology.

The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II

M. Rowe, J. Zuo, Laura L. Quinn, 2015, Journal of Virology.

University of Birmingham The missing link in EBV immune evasion

M. Rowe, J. Zuo, Laura L. Quinn, 2015 .

CAR T‐Cell Therapy Effects: Review of procedures and patient education

C. Callahan, Megan Harvey, Holly McConville, 2017 .

Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.

D. Teachey, S. Grupp, C. June, 2022, Blood.

Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+ acute lymphoblastic leukemia (ALL).

D. Teachey, S. Grupp, B. Levine, 2017 .

The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II

M. Rowe, J. Zuo, Laura L. Quinn, 2015, Journal of Virology.

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

D. Teachey, S. Grupp, D. Porter, 2016 .